After a median follow-up of @ months ( IQR @-@ ) , median time to progression was significantly longer in the salvage ASCT than in the cyclophosphamide group ( @ months -LSB- @ % CI @-@ -RSB- vs @ months -LSB- @-@ -RSB- ; hazard ratio @ -LSB- @ % CI @-@ -RSB- ; p < @ ) .